Vaccination cuts risk of COVID-19 respiratory failure or death by 80%

Researchers at Vanderbilt Health and around the country continue to evaluate the effectiveness of vaccines approved by the Food and Drug Administration to reduce the severity and lethality of respiratory infections caused by the ever-mutating SARS-CoV-2 virus.

Vanderbilt research uncovers new clue to insulin resistance

The latest findings could lead to more targeted ways to increase insulin-stimulated glucose uptake by muscle and exercise tolerance.

Vanderbilt Health’s Vineet Agrawal, Fabian Bock among 2026 ASCI Young Physician-Scientist awardees

Since 2014, 27 Vanderbilt faculty members have received the annual award, which recognizes “notable achievements” by researchers early in their first faculty appointments.

Broad genetic study reveals new drug target for asthma

The findings could bring relief to the more than 26 million people in the United States with asthma, a chronic and complex inflammatory disease of the airways.

Translational Science & Research Forum to be Feb. 18

A grateful patient says ‘thank you’ to Vanderbilt Medical Laboratories

The infection can result from inhaling spores of the fungus Histoplasma capsulatum, which grows in soil throughout Middle Tennessee, especially in soil contaminated with bird or bat droppings. Previously, blood samples had to be sent to a reference lab in Utah.